HolderBook

COEPTIS THERAPEUTICS HLDGS I (COEP)

Institutional ownership reported to the SEC as of Q1 2026, across 15 quarters.

13
Reporting holders
$5.4M
Reported value
0.0%
Held as options
-2
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
VANGUARD CAPITAL MANAGEMENT LLC$3.6M320,7310.00%newFIRST
GEODE CAPITAL MANAGEMENT, LLC$596.1K53,0930.00%5q+26.1%+$123.5K
STATE STREET CORP$301.0K26,8300.00%3qHELD
VANGUARD FIDUCIARY TRUST CO$275.7K24,5730.00%newFIRST
UNITED CAPITAL FINANCIAL ADVISORS, LLC$224.4K20,0000.00%newNEW
BlackRock, Inc.$152.2K13,5660.00%2qHELD
NORTHERN TRUST CORP$137.1K12,2190.00%2qHELD
Anchor Investment Management, LLC$78.5K7,0000.01%3qHELD
Steward Partners Investment Advisory, LLC$56.1K5,0000.00%6qHELD
Vanguard Global Advisers, LLC$18.7K1,6710.00%newFIRST
MORGAN STANLEY$2.3K2010.00%3q+0.5%
OSAIC HOLDINGS, INC.$1.1K1000.00%2qHELD
BARCLAYS PLC$3430.00%5qHELD

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q1 202613$5.4M484,9871200.0%
Q4 202515$6.6M465,1636510.0%
Q3 202511$2.5M144,6205410.0%
Q2 20259$794.9K101,9121320.0%
Q1 20259$517.6K55,2424210.0%
Q4 20246$44.8K8,5715000.0%
Q3 202413$288.8K1,605,0593130.0%
Q2 202413$442.0K1,529,2373110.0%
Q1 202417$1.4M4,597,3044320.0%
Q4 202317$3.6M4,615,9635610.0%
Q3 202313$3.7M3,179,9413410.0%
Q2 202313$5.0M3,221,2016300.0%
Q1 20238$239.9K166,8206100.0%
Q4 20227$5.5M3,573,8877000.0%
Q3 20221$360.0K35,3701000.0%